Cargando…

MMP-9/Gelatinase B Degrades Immune Complexes in Systemic Lupus Erythematosus

Systemic Lupus Erythematosus (SLE) is a common and devastating autoimmune disease, characterized by a dysregulated adaptive immune response against intracellular antigens, which involves both autoreactive T and B cells. In SLE, mainly intracellular autoantigens generate autoantibodies and these asse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ugarte-Berzal, Estefania, Boon, Lise, Martens, Erik, Rybakin, Vasily, Blockmans, Daniel, Vandooren, Jennifer, Proost, Paul, Opdenakker, Ghislain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440319/ https://www.ncbi.nlm.nih.gov/pubmed/30967870 http://dx.doi.org/10.3389/fimmu.2019.00538

Ejemplares similares

EDTA/gelatin zymography method to identify C1s versus activated MMP‐9 in plasma and immune complexes of patients with systemic lupus erythematosus
por: Ugarte‐Berzal, Estefania, et al.
Publicado: (2018)

Endotoxemia shifts neutrophils with TIMP-free gelatinase B/MMP-9 from bone marrow to the periphery and induces systematic upregulation of TIMP-1
por: Vandooren, Jennifer, et al.
Publicado: (2017)

Gelatinase B/Matrix Metalloproteinase-9 as Innate Immune Effector Molecule in Achalasia
por: Furuzawa-Carballeda, Janette, et al.
Publicado: (2018)

Gelatinase B/matrix metalloproteinase-9 is a phase-specific effector molecule, independent from Fas, in experimental autoimmune encephalomyelitis
por: Ugarte-Berzal, Estefania, et al.
Publicado: (2018)

Neutrophils and Activated Macrophages Control Mucosal Immunity by Proteolytic Cleavage of Antileukoproteinase
por: Vandooren, Jennifer, et al.
Publicado: (2018)

Propeptide glycosylation and galectin‐3 binding decrease proteolytic activation of human proMMP‐9/progelatinase B
por: Boon, Lise, et al.
Publicado: (2018)

Glycosylation of matrix metalloproteases and tissue inhibitors: present state, challenges and opportunities
por: Boon, Lise, et al.
Publicado: (2016)

Thymocyte development in the absence of matrix metalloproteinase-9/gelatinase B
por: Gounko, Natalia V., et al.
Publicado: (2016)

Proteoform Analysis of Matrix Metalloproteinase-9/Gelatinase B and Discovery of Its Citrullination in Rheumatoid Arthritis Synovial Fluids
por: Grillet, Bernard, et al.
Publicado: (2021)

Heterogeneity of serum gelatinases MMP-2 and MMP-9 isoforms and charge variants
por: Rossano, Rocco, et al.
Publicado: (2014)

Internal Disulfide Bonding and Glycosylation of Interleukin-7 Protect Against Proteolytic Inactivation by Neutrophil Metalloproteinases and Serine Proteases
por: Vandooren, Jennifer, et al.
Publicado: (2021)

Bivalent Inhibitor with Selectivity for Trimeric MMP-9 Amplifies Neutrophil Chemotaxis and Enables Functional Studies on MMP-9 Proteoforms
por: Nuti, Elisa, et al.
Publicado: (2020)

Differential inhibition of activity, activation and gene expression of MMP-9 in THP-1 cells by azithromycin and minocycline versus bortezomib: A comparative study
por: Vandooren, Jennifer, et al.
Publicado: (2017)

Physiological fibrin hydrogel modulates immune cells and molecules and accelerates mouse skin wound healing
por: Pereira, Rafaela Vaz Sousa, et al.
Publicado: (2023)

Inhibition of Neutrophil Collagenase/MMP-8 and Gelatinase B/MMP-9 and Protection against Endotoxin Shock
por: Qiu, Zheng, et al.
Publicado: (2014)

Chlorite-Oxidized Oxyamylose (COAM) Has Antibacterial Activity and Positively Affects Skin Wound Healing
por: Pereira, Rafaela Vaz Sousa, et al.
Publicado: (2022)

Association of the Gelatinase B/Metalloproteinase 9 (MMP-9) Gene Haplotype in Systemic Lupus Erythematosus (SLE) in the Pediatric Egyptian Population
por: Attia, Zeinab R., et al.
Publicado: (2022)

Inhibition of gelatinase B/MMP-9 does not attenuate colitis in murine models of inflammatory bowel disease
por: de Bruyn, Magali, et al.
Publicado: (2017)

The Biological Potential Hidden in Inclusion Bodies
por: Gifre-Renom, Laia, et al.
Publicado: (2020)

Recombinant Protein-Based Nanoparticles: Elucidating Their Inflammatory Effects In Vivo and Their Potential as a New Therapeutic Format
por: Gifre-Renom, Laia, et al.
Publicado: (2020)

Higher Content but No Specific Activity in Gelatinase B (MMP-9) Compared with Gelatinase A (MMP-2) in Human Renal Carcinoma
por: Młynarczyk, Grzegorz, et al.
Publicado: (2023)

Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy.
por: Parsons, S. L., et al.
Publicado: (1998)

Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression
por: Farina, Antonietta Rosella, et al.
Publicado: (2014)

How to place the duality of specific MMP-9 inhibition for treatment of inflammatory bowel diseases into clinical opportunities?
por: Opdenakker, Ghislain, et al.
Publicado: (2022)

Comparisons of gut microbiota profiles in wild-type and gelatinase B/matrix metalloproteinase-9-deficient mice in acute DSS-induced colitis
por: de Bruyn, Magali, et al.
Publicado: (2018)

Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas
por: Forsyth, P A, et al.
Publicado: (1999)

Role of Gelatinases MMP-2 and MMP-9 in Healthy and Complicated Pregnancy and Their Future Potential as Preeclampsia Biomarkers
por: Nikolov, Asparuh, et al.
Publicado: (2021)

Roles of CD147 on T lymphocytes activation and MMP-9 secretion in Systemic Lupus Erythematosus
por: Pistol, Gina, et al.
Publicado: (2007)

Matrix Metalloproteinase-9-Generated COOH-, but Not NH(2)-Terminal Fragments of Serum Amyloid A1 Retain Potentiating Activity in Neutrophil Migration to CXCL8, With Loss of Direct Chemotactic and Cytokine-Inducing Capacity
por: Gouwy, Mieke, et al.
Publicado: (2018)

Natural Marine and Terrestrial Compounds as Modulators of Matrix Metalloproteinases-2 (MMP-2) and MMP-9 in Alzheimer’s Disease
por: Ciccone, Lidia, et al.
Publicado: (2021)

Gelatinase (MMP-2 and -9) expression profiles during gestation in the bovine endometrium
por: Kizaki, Keiichiro, et al.
Publicado: (2008)

Urinary Neutrophil Gelatinase-Associated Lipocalin Is a Potential Biomarker for Renal Damage in Patients with Systemic Lupus Erythematosus
por: Yang, Chun-Chen, et al.
Publicado: (2012)

Synergistic effect of collagenase-1 (MMP1), stromelysin-1 (MMP3) and gelatinase-B (MMP9) gene polymorphisms in breast cancer
por: Padala, Chiranjeevi, et al.
Publicado: (2017)

MMP-9 and MMP-2 gelatinases and TIMP-1 and TIMP-2 inhibitors in breast cancer: correlations with prognostic factors
por: Jinga, D C, et al.
Publicado: (2006)

Neutrophil Gelatinase-Associated Lipocalin (NGAL), Pro-Matrix Metalloproteinase-9 (pro-MMP-9) and Their Complex Pro-MMP-9/NGAL in Leukaemias
por: Bouchet, Sandrine, et al.
Publicado: (2014)

From ELISA to Immunosorbent Tandem Mass Spectrometry Proteoform Analysis: The Example of CXCL8/Interleukin-8
por: Metzemaekers, Mieke, et al.
Publicado: (2021)

Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease
por: Provatopoulou, Xeni, et al.
Publicado: (2009)

Bone sialoprotein does not interact with pro-gelatinase A (MMP-2) or mediate MMP-2 activation
por: Hwang, Queena, et al.
Publicado: (2009)

Systemic Lupus Erythematosus and DNA Degradation and Elimination Defects
por: Arneth, Borros
Publicado: (2019)

Evaluation of neutrophil gelatinase-associated lipocalin (NGAL), matrix metalloproteinase-9 (MMP-9) and their complex MMP-9/NGAL in sera and urine of patients with kidney tumors
por: DI CARLO, ANGELINA
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_m9nvosit30h37mb98rdj96u5dv